Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
01/21/1999 | WO1999002497A2 Pyridine derivatives |
01/21/1999 | WO1999002496A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
01/21/1999 | WO1999002494A1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
01/21/1999 | WO1999002485A1 Branched chain fatty acids, their derivatives and use in the treatment of central nervous system disorders |
01/21/1999 | WO1999002479A1 Method for producing calcium pyruvates |
01/21/1999 | WO1999002215A1 Treatment of inflammatory disorders of the bowel and urinary bladder |
01/21/1999 | WO1999002189A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
01/21/1999 | WO1999002178A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
01/21/1999 | WO1999002175A1 Conjugates useful in the treatment of prostate cancer |
01/21/1999 | WO1999002170A1 Absorption of minerals by intestinal cells |
01/21/1999 | WO1999002168A1 Novel polymeric compositions |
01/21/1999 | WO1999002167A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
01/21/1999 | WO1999002166A1 Use of colchinol derivatives as vascular damaging agents |
01/21/1999 | WO1999002165A1 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma |
01/21/1999 | WO1999002164A1 Method and composition for treatment of erectile dysfunction |
01/21/1999 | WO1999002163A1 Inhibitors of neutrophil mediated oxidant production |
01/21/1999 | WO1999002162A1 Cyclin dependent kinase inhibiting purine derivatives |
01/21/1999 | WO1999002161A1 Use of phosphordiesterase inhibitors in the treatment of prostatic diseases |
01/21/1999 | WO1999002159A1 Aroylpiperazines for modulating sexual activity |
01/21/1999 | WO1999002158A1 Stable medicinal compositions containing 4,5-epoxymorphinane derivatives |
01/21/1999 | WO1999002156A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates |
01/21/1999 | WO1999002155A1 Imidazole derivatives as mdr modulators |
01/21/1999 | WO1999002154A1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
01/21/1999 | WO1999002152A1 Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for increasing insulin sensitivity |
01/21/1999 | WO1999002150A1 β-ALKOXYACRYLATES AGAINST MALARIA |
01/21/1999 | WO1999002149A1 Use of petroselinum acid for treating inflammations |
01/21/1999 | WO1999002148A1 Nitric oxide inhibits rhinovirus infection |
01/21/1999 | WO1999002147A1 Improved methods and compositions for treating male erectile dysfunction |
01/21/1999 | WO1999002144A1 Anion regulator for ruminants |
01/21/1999 | WO1999002143A2 Medicament comprising adenosine |
01/21/1999 | WO1999002142A2 Novel composition comprising an ssri and a beta-blocker |
01/21/1999 | WO1999002141A1 Block copolymer |
01/21/1999 | WO1999002140A1 Process for preparing fast dispersing solid oral dosage form |
01/21/1999 | WO1999002134A2 Method for producing active agent preparations with controlled release from a matrix |
01/21/1999 | WO1999002133A2 Topical application of a combination of benzoyl peroxide and a second active ingredient |
01/21/1999 | WO1999002132A2 Use of submicron oil-in-water emulsions with dna vaccines |
01/21/1999 | WO1999002130A2 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
01/21/1999 | WO1999002041A1 Satiety product |
01/21/1999 | WO1998047491A3 Controlled release formulations using intelligent polymers |
01/21/1999 | WO1998046193A3 Synergistic method for treating a neoplasm |
01/21/1999 | WO1998042324A3 Methods for modulating neurotrophic factor-associated activity using aldose reductase inhibitors |
01/21/1999 | WO1998035658A3 The use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone |
01/21/1999 | DE19731591A1 Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie Pharmaceutical preparations containing perfluoroalkyl Trijodaromaten and their use in cancer therapy and interventional radiology |
01/21/1999 | DE19730989A1 Piperazin-Derivate Piperazine derivatives |
01/21/1999 | DE19730451A1 Treating or preventing endothelial dysfunction disorders |
01/21/1999 | DE19727350C1 Verfahren zur Herstellung von Nifedipin A process for the preparation of nifedipine |
01/21/1999 | CA2303430A1 Nitric oxide inhibits rhinovirus infection |
01/21/1999 | CA2303210A1 Salts of diphosphonic acids and amino-alcohols for the treatment of osteoporosis |
01/21/1999 | CA2298834A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
01/21/1999 | CA2297187A1 Tropane analogs and methods for inhibition of monoamine transport |
01/21/1999 | CA2296440A1 5-(3-phenyl-3-oxo-propyl)-1h-tetrazole derivatives |
01/21/1999 | CA2296434A1 Mutations in the myostatin gene cause double-muscling in mammals |
01/21/1999 | CA2296102A1 Triazole compounds and the use thereof as dopamine-d3-ligands |
01/21/1999 | CA2296037A1 4,5-dihydro-¬1h|-benz¬g|indazole-3-carboxylic acid derivatives |
01/21/1999 | CA2296033A1 Novel compounds |
01/21/1999 | CA2296017A1 Method for producing calcium pyruvates |
01/21/1999 | CA2295976A1 Block copolymer |
01/21/1999 | CA2295935A1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
01/21/1999 | CA2295860A1 Conjugates useful in the treatment of prostate cancer |
01/21/1999 | CA2295822A1 Novel composition |
01/21/1999 | CA2295800A1 Resolution of amines |
01/21/1999 | CA2295740A1 Use of submicron oil-in-water emulsions with dna vaccines |
01/21/1999 | CA2295721A1 Method and composition for treatment of erectile dysfunction |
01/21/1999 | CA2295715A1 Compounds derived from thophene and benzothiophene, and related utilisation and composition |
01/21/1999 | CA2295697A1 Inhibitors of neutrophil mediated oxidant production |
01/21/1999 | CA2295666A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
01/21/1999 | CA2295640A1 Aroylpiperazines for modulating sexual activity |
01/21/1999 | CA2295629A1 Erythromycin a oxime solvates |
01/21/1999 | CA2295626A1 Novel compounds |
01/21/1999 | CA2295595A1 Improved methods and compositions for treating male erectile dysfunction |
01/21/1999 | CA2295474A1 123 human secreted proteins |
01/21/1999 | CA2295375A1 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
01/21/1999 | CA2294931A1 .beta.-alkoxyacrylates against malaria |
01/21/1999 | CA2294817A1 Use of petroselinum acid for treating inflammations |
01/21/1999 | CA2294779A1 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma |
01/21/1999 | CA2294757A1 Anion regulator for ruminants |
01/21/1999 | CA2294752A1 Pak kinase genes and polypeptides and methods of use thereof |
01/21/1999 | CA2294732A1 Ctl epitopes from ebv |
01/21/1999 | CA2294533A1 6-azauracil derivatives as il-5 inhibitors |
01/21/1999 | CA2294293A1 Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents |
01/21/1999 | CA2294244A1 Cyclin dependent kinase inhibiting purine derivatives |
01/21/1999 | CA2294145A1 Il-5 inhibiting 6-azauracil derivatives |
01/21/1999 | CA2292480A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
01/21/1999 | CA2292451A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
01/21/1999 | CA2290038A1 Chaperone fragments |
01/21/1999 | CA2265671A1 Matrix metalloproteinase inhibitors |
01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
01/20/1999 | EP0892063A2 Histidine kinase |
01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
01/20/1999 | EP0892057A2 Response regulator |
01/20/1999 | EP0892056A2 GidA1 polypeptides from Chlamydia trachomitis |
01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
01/20/1999 | EP0891981A1 Tylosin secomacrolide compounds |
01/20/1999 | EP0891979A1 A crystalline form of monohydrate monosodium salt of the N,N-Dimethyl-3-amino-1-Hydroxypropan-1,1-Disphosphonic acid and the procedure for its preparation |
01/20/1999 | EP0891978A2 5H-Thiazolo (3,2-a) pyrimidine derivatives |
01/20/1999 | EP0891976A1 Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents |
01/20/1999 | EP0891776A1 Simethicone/anhydrous calcium phosphate compositions |
01/20/1999 | EP0891775A1 Remedies for bladder disorders |
01/20/1999 | EP0891774A2 Process for producing sustained release preparation |